Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $50.3 million.

  • Agilon Health's Other Non-Current Liabilities fell 3063.67% to $50.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.3 million, marking a year-over-year decrease of 3063.67%. This contributed to the annual value of $76.1 million for FY2024, which is 815.56% up from last year.
  • Latest data reveals that Agilon Health reported Other Non-Current Liabilities of $50.3 million as of Q3 2025, which was down 3063.67% from $54.9 million recorded in Q2 2025.
  • Over the past 5 years, Agilon Health's Other Non-Current Liabilities peaked at $94.3 million during Q4 2021, and registered a low of $50.3 million during Q3 2025.
  • Over the past 5 years, Agilon Health's median Other Non-Current Liabilities value was $76.1 million (recorded in 2024), while the average stood at $77.4 million.
  • Per our database at Business Quant, Agilon Health's Other Non-Current Liabilities skyrocketed by 815.56% in 2024 and then plummeted by 3063.67% in 2025.
  • Quarter analysis of 5 years shows Agilon Health's Other Non-Current Liabilities stood at $94.3 million in 2021, then dropped by 12.52% to $82.5 million in 2022, then dropped by 14.68% to $70.4 million in 2023, then increased by 8.16% to $76.1 million in 2024, then tumbled by 33.94% to $50.3 million in 2025.
  • Its last three reported values are $50.3 million in Q3 2025, $54.9 million for Q2 2025, and $57.9 million during Q1 2025.